AB Science will be granted a patent, valid through 2040, covering the medical use of masitinib as a treatment for sickle cell ...

Variations in inflammation may contribute to vaso-occlusive events (VOEs) during the menstrual cycles of women with SCD, per ...

Avascular necrosis in sickle cell disease can occur due to the impairment of blood supply to the bones, writes columnist.